TipRanks gives China Life stock HKD 38.50 target

Published on 10/14/2026 at 17:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-half profit rose 228.60 percent to RMB 134.489 billion. China Life stock costs EUR 2.85 on October 14, 2026, down 2.65 percent on HKEX.

Analysts and operating figures

TipRanks lists a Buy rating and HKD 38.50 target on September 25, 2026, 54.37 percent above HKD 24.94.
China Life reported RMB 134.489 billion in first-half 2026 net profit, up 228.60 percent year over year.
China Life stock costs EUR 2.85 at Lang & Schwarz on October 14, 2026 at 5:05 p.m. CEST, down 2.65 percent on HKEX.
Next reporting earnings are scheduled for October 29, 2026, while the price-to-earnings ratio is 3.92.

China Life, CNE1000002L3, Illustration mit AI erstellt.

According to The Globe and Mail on September 25, 2026, TipRanks listed a Buy rating and HKD 38.50 target for China Life stock. Against the HKEX price of HKD 24.94 on October 14, 2026, that target stood 54.37 percent higher. China Life stock was trading at EUR 2.85 at Lang & Schwarz on October 14, 2026 at 5:05 p.m. CEST, down 2.65 percent on HKEX.

Profit more than doubled

China Life's first-half 2026 results supplied the operating counterweight to the valuation debate. Futunn reported net profit attributable to shareholders of RMB 134.489 billion, up 228.60 percent from the same period of 2025. Excluding short-term public-market equity effects, profit rose 12.70 percent to RMB 57.608 billion.

The same first-half report put New Business Value at RMB 38.167 billion, an increase of 33.70 percent year over year. Total investment income reached RMB 314.504 billion, while total investment yield rose to 5.58 percent from the year-earlier period.

Stock remains below its yearly high

The HKEX quote stood at HKD 24.94 on October 14, 2026, versus a 52-week range of HKD 22.30 to HKD 36.16. The price was 31.03 percent below the yearly high and 11.84 percent above the low. Trading volume reached 88,199,269 shares against an average of 49,444,331.

Valuation and reporting date

China Life's market capitalization was HKD 1.1 trillion on October 14, 2026, and its price-to-earnings ratio was 3.92. Simply Wall St lists October 29, 2026 as the next reporting earnings date.

Comparison with peers

China Life (HKEX, HKD): down 2.65 percent, P/E 3.92, market capitalization HKD 1.1 trillion.

Ping An Insurance (HKEX, HKD): down 1.46 percent, P/E 5.81, market capitalization HKD 916.2 billion.

China Pacific Insurance (HKEX, HKD): down 1.67 percent, P/E 5.00, market capitalization HKD 261.3 billion.

Price and trading position

China Life stock was trading at EUR 2.85 at Lang & Schwarz on October 14, 2026 at 5:05 p.m. CEST. The HKEX price was 2.65 percent below the HKD 25.62 close of October 13, 2026. The further course of trading is shown by the continuously updated real-time quote of China Life stock.